Related references
Note: Only part of the references are listed.Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune Encephalomyelitis
Tommaso Bonfiglio et al.
PLOS ONE (2017)
Presynaptic, release-regulating mGlu2-preferring and mGlu3-preferring autoreceptors in CNS: pharmacological profiles and functional roles in demyelinating disease
Silvia Di Prisco et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
CXCR4 and NMDA Receptors Are Functionally Coupled in Rat Hippocampal Noradrenergic and Glutamatergic Nerve Endings
Silvia Di Prisco et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2016)
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis
Antonietta Gentile et al.
JOURNAL OF NEUROINFLAMMATION (2016)
RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis
Francesco Mori et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
CCR5 blockade for neuroinflammatory diseases - beyond control of HIV
Guillaume Martin-Blondel et al.
NATURE REVIEWS NEUROLOGY (2016)
CCR5 knockout suppresses experimental autoimmune encephalomyelitis in C57BL/6 mice
Sun Mi Gu et al.
ONCOTARGET (2016)
RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis
Francesco Mori et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Presynaptic Release-Regulating mGlu1 Receptors in Central Nervous System
Anna Pittaluga
FRONTIERS IN PHARMACOLOGY (2016)
The complex contribution of chemokines to neuroinflammation: switching from beneficial to detrimental effects
Ophelia Le Thuc et al.
NEUROIMMUNOMODULATION IN HEALTH AND DISEASE (2015)
Sphingosine-1-phosphate inhibits IL-1-induced expression of C-C motif ligand 5 via c-Fos-dependent suppression of IFN-β amplification loop
Jessie W. Yester et al.
FASEB JOURNAL (2015)
Immune parameters of patients treated with laquinimod, a novel oral therapy for the treatment of multiple sclerosis: results from a double-blind placebo-controlled study
Mariusz Stasiolek et al.
IMMUNITY INFLAMMATION AND DISEASE (2015)
Acute desipramine restores presynaptic cortical defects in murine experimental autoimmune encephalomyelitis by suppressing central CCL5 overproduction
Silvia Di Prisco et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Biomarkers for Multiple Sclerosis
Ryo Tomioka et al.
INTERNAL MEDICINE (2014)
The inhibition of Rho kinase blocks cell migration and accumulation possibly by challenging inflammatory cytokines and chemokines on astrocytes
Min-Fang Guo et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
Functional Adaptation of Presynaptic Chemokine Receptors in EAE Mouse Central Nervous System
Silvia Di Prisco et al.
SYNAPSE (2014)
Nicotinic α7 receptor activation selectively potentiates the function of NMDA receptors in glutamatergic terminals of the nucleus accumbens
Stefania Zappettini et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Chemokines in the balance: maintenance of homeostasis and protection at CNS barriers
Jessica L. Williams et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
CCL5 and cytokine expression in the rat brain: Differential modulation by chronic morphine and morphine withdrawal
Lee A. Campbell et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis
G. Grasselli et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Relationship Between the Chemokine Receptor CCR5 and Microglia in Neurological Disorders: Consequences of Targeting CCR5 on Neuroinflammation, Neuronal Death and Regeneration in a Model of Epilepsy
Jean-Pierre Louboutin et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2013)
Glatiramer Acetate Protects Against Inflammatory Synaptopathy in Experimental Autoimmune Encephalomyelitis
Antonietta Gentile et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Increased excitability in tat-transgenic mice: Role of tat in HIV-related neurological disorders
Silvia Zucchini et al.
NEUROBIOLOGY OF DISEASE (2013)
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
M. Mecha et al.
NEUROBIOLOGY OF DISEASE (2013)
Microglia: New Roles for the Synaptic Stripper
Helmut Kettenmann et al.
NEURON (2013)
CCL5-glutamate interaction in central nervous system: Early and acute presynaptic defects in EAE mice
Silvia Di Prisco et al.
NEUROPHARMACOLOGY (2013)
Presynaptic mGlu7 receptors control GABA release in mouse hippocampus
Maria Summa et al.
NEUROPHARMACOLOGY (2013)
Inflammation Subverts Hippocampal Synaptic Plasticity in Experimental Multiple Sclerosis
Robert Nistico et al.
PLOS ONE (2013)
Microglia: actively surveying and shaping neuronal circuit structure and function
Hiroaki Wake et al.
TRENDS IN NEUROSCIENCES (2013)
RANTES-mediated control of excitatory amino acid release in mouse spinal cord
Silvia Di Prisco et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis
Sonia Batista et al.
JOURNAL OF NEUROLOGY (2012)
In vitro exposure to nicotine induces endocytosis of presynaptic AMPA receptors modulating dopamine release in rat nucleus accumbens nerve terminals
Massimo Grilli et al.
NEUROPHARMACOLOGY (2012)
Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects
Eva de Lago et al.
NEUROPHARMACOLOGY (2012)
Evaluation of Serum Levels of Chemokines during Interferon-β Treatment in Multiple Sclerosis Patients
Elizabeth R. Comini-Frota et al.
CNS DRUGS (2011)
Pre-synaptic glycine GlyT1 transporter - NMDA receptor interaction: relevance to NMDA autoreceptor activation in the presence of Mg2+ ions
Veronica Musante et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Regulation of microglia by ionotropic glutamatergic and GABAergic neurotransmission
Wai T. Wong et al.
NEURON GLIA BIOLOGY (2011)
Hippocampal AMPA autoreceptors positively coupled to NMDA autoreceptors traffic in a constitutive manner and undergo adaptative changes following enriched environment training
Maria Summa et al.
NEUROPHARMACOLOGY (2011)
The chemokine receptor CCR5 in the central nervous system
Silvia Sorce et al.
PROGRESS IN NEUROBIOLOGY (2011)
Astrocytes modulate the chemokine network in a pathogen-specific manner
Clive S. McKimmie et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Expression of chemokine receptors on peripheral blood lymphocytes in multiple sclerosis and neuromyelitis optica
Akiyuki Uzawa et al.
BMC NEUROLOGY (2010)
The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis
D. Centonze et al.
CELL DEATH AND DIFFERENTIATION (2010)
Morphine Induces the Release of CCL5 from Astrocytes: Potential Neuroprotective Mechanism Against the HIV Protein gp120
Valeriya Avdoshina et al.
GLIA (2010)
β-Chemokine production by neural and glial progenitor cells is enhanced by HIV-1 Tat: effects on microglial migration
Yun Kyung Hahn et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Alterations of glutamate release in the spinal cord of mice with experimental autoimmune encephalomyelitis
Antonella Marte et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Noradrenaline reuptake inhibitors inhibit expression of chemokines IP-10 and RANTES and cell adhesion molecules VCAM-1 and ICAM-1 in the CNS following a systemic inflammatory challenge
Joan B. O'Sullivan et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation
Francesca Fallarino et al.
NATURE MEDICINE (2010)
Maraviroc: A coreceptor CCR5 antagonist for management of HIV infection
Raymond Yost et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2009)
Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration
Joan B. O'Sullivan et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)
Inhibition of Ca2+-dependent glutamate release from cerebral cortex synaptosomes of rats with experimental autoimmune encephalomyelitis
Aldo Alejandro Vilcaes et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Expression of Chemokines and Their Receptors by Human Brain Endothelium: Implications for Multiple Sclerosis
Eve A. Subileau et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Inflammation Triggers Synaptic Alteration and Degeneration in Experimental Autoimmune Encephalomyelitis
Diego Centonze et al.
JOURNAL OF NEUROSCIENCE (2009)
Blockade of Glutamate Release from Microglia Attenuates Experimental Autoimmune Encephalomyelitis in Mice
Jin Shijie et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in 5/6 nephrectomized rats
Matthias Schaier et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Multiple sclerosis: An immune or neurodegenerative disorder?
Bruce D. Trapp et al.
ANNUAL REVIEW OF NEUROSCIENCE (2008)
Chemokines and their receptors: Drug targets in immunity and inflammation
Antonella Viola et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Myelin-induced microglial neurotoxicity can be controlled by microglial metabotropic glutamate receptors
F. Pinteaux-Jones et al.
JOURNAL OF NEUROCHEMISTRY (2008)
CCL5/RANTES Gene Deletion Attenuates Opioid-Induced Increases in Glial CCL2/MCP-1 Immunoreactivity and Activation in HIV-1 Tat-Exposed Mice
Nazira El-Hage et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2008)
The use of chemokine antagonists in EAE models
Amanda E. I. Proudfoot et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
RANTES Modulates the Release of Glutamate in Human Neocortex
Veronica Musante et al.
JOURNAL OF NEUROSCIENCE (2008)
Therapeutic targeting of chemokine signaling in Multiple Sclerosis
Isabel Hamann et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Presynaptic mGlu1 and mGlu5 autoreceptors facilitate glutamate exocytosis from mouse cortical nerve endings
Veronica Musante et al.
NEUROPHARMACOLOGY (2008)
Switch in the expression of mGlu1 and mGlu5 metabotropic glutamate receptors in the cerebellum of mice developing experimental autoimmune encephalomyelitis and in autoptic cerebellar samples from patients with multiple sclerosis
F. Fazio et al.
NEUROPHARMACOLOGY (2008)
Functional interactions between presynaptic NMDA receptors and metabotropic glutamate receptors co-expressed on rat and human noradrenergic terminals
E. Luccini et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Neuronal 'On' and 'Off' signals control microglia
Knut Biber et al.
TRENDS IN NEUROSCIENCES (2007)
Opinion -: Chemokines:: a new class of neuromodulator?
William Rostene et al.
NATURE REVIEWS NEUROSCIENCE (2007)
CCL5 and CCR5 genotypes modify clinical, radiological and pathological features of multiple sclerosis
Tineke van Veen et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Chemokines and chemokine receptors in neurological disease: Raise, retain, or reduce?
Carine Savarin-Vuaillat et al.
NEUROTHERAPEUTICS (2007)
Neurotransmitter receptors on microglia
Jennifer M. Pocock et al.
TRENDS IN NEUROSCIENCES (2007)
Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients
Paola Sarchielli et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus
Anna Pittaluga et al.
NEUROPHARMACOLOGY (2007)
Evidence that α7 nicotinic receptor modulates glutamate release from mouse neocortical gliosomes
Laura Patti et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Brain atrophy and cognitive impairment in multiple sclerosis: a review
Michael Lanz et al.
JOURNAL OF NEUROLOGY (2007)
Dual role of inflammation in CNS disease
Reinhard Hohlfeld et al.
NEUROLOGY (2007)
Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies
Adam Szczucinski et al.
ACTA NEUROLOGICA SCANDINAVICA (2007)
Group I mGlu receptor stimulation inhibits activation-induced cell death of human T lymphocytes
Annalisa Chiocchetti et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
RANTES stimulates Ca2+ mobilization and inositol trisphosphate (IP3) formation in cells transfected with G protein-coupled receptor 75
A. Ignatov et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis
M. Krakauer et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2006)
The human immunodeficiency virus-1 protein transactivator of transcription up-regulates N-methyl-D-aspartate receptor function by acting at metabotropic glutamate receptor 1 receptors coexisting on human and rat brain noradrenergic neurones
Fabio Longordo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Microglial expression of chemokine receptor CCR5 during rat forebrain development and after perinatal hypoxia-ischemia
RM Cowell et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Trafficking of presynaptic AMPA receptors mediating neurotransmitter release: Neuronal selectivity and relationships with sensitivity to cyclothiazide
A Pittaluga et al.
NEUROPHARMACOLOGY (2006)
Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation
IF Charo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Glia re-sealed particles freshly prepared from adult rat brain are competent for exocytotic release of glutamate
S Stigliani et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Chemokine blockers - therapeutics in the making?
TNC Wells et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
The expression and function of chemokines involved in CNS inflammation
EE Ubogu et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Immunological patterns identifying disease course and evolution in multiple sclerosis patients
R Furlan et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Correlations between IL-4, IL-12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patients
H Bartosik-Psujek et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Depression in multiple sclerosis: a review
RJ Siegert et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor α-induced neurotoxicity in concert with microglial-derived fas ligand
DL Taylor et al.
JOURNAL OF NEUROSCIENCE (2005)
Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases
L Cartier et al.
BRAIN RESEARCH REVIEWS (2005)
Viewing chemokines as a third major system of communication in the brain
MW Adler et al.
AAPS JOURNAL (2005)
An antidepressant mechanism of desipramine is to decrease tumor necrosis factor-alpha production culminating in increases in noradrenergic neurotransmission
JL Reynolds et al.
NEUROSCIENCE (2005)
Somatostatin inhibits glutamate release from mouse cerebrocortical nerve endings through presynaptic sst2 receptors linked to the adenylyl cyclase-protein kinase A pathway
M Grilli et al.
NEUROPHARMACOLOGY (2004)
Proinflammatory chemokines, such as C-C chemokine ligand 3, desensitize μ-opioid receptors on dorsal root ganglia neurons
N Zhang et al.
JOURNAL OF IMMUNOLOGY (2004)
Chemokines in innate and adaptive host defense: Basic chemokinese grammar for immune cells
A Rot et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Cytokine-directed therapies for the treatment of chronic airway diseases
PJ Barnes
CYTOKINE & GROWTH FACTOR REVIEWS (2003)
Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis
JJG Geurts et al.
BRAIN (2003)
Chemokine upregulation follows cytokine expression in chronic relapsing experimental autoimmune encephalomyelitis
AR Glabinski et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2003)
Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration
Y Ganor et al.
JOURNAL OF IMMUNOLOGY (2003)
Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes
GJ Guillemin et al.
GLIA (2003)
Regulation of chemokine receptor expression in human microglia and astrocytes
G Flynn et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Expression of chemokines and their receptors in human and simian astrocytes:: Evidence for a central role of TNFα and IFNγ in CXCR4 and CCR5 modulation
J Croitoru-Lamoury et al.
GLIA (2003)
Chemokine receptors on infiltrating leucocytes in inflammatory pathologies of the central nervous system (CNS)
C Trebst et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2003)
A new possible mechanism of human immunodeficiency virus type 1 infection of neural cells
SA Losada et al.
NEUROBIOLOGY OF DISEASE (2002)
Chemokine receptors and neural function
C Cho et al.
JOURNAL OF NEUROVIROLOGY (2002)
Frequencies of the G-protein β3 subunit C825T polymorphism and the δ 32 mutation of the chemokine receptor-5 in patients with multiple sclerosis
CG Haase et al.
NEUROSCIENCE LETTERS (2002)
Characterization of chemokines and their receptors in the central nervous system: physiopathological implications
A Bajetto et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES
M Matsui et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
RANTES stimulates inflammatory cascades and receptor modulation in murine astrocytes
Y Luo et al.
GLIA (2002)
Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes
TO Jalonen et al.
JOURNAL OF NEUROLOGY (2002)
Altered expression of glutamate transporters in experimental autoimmune encephalomyelitis
M Ohgoh et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Regulation of calcium currents by chemokines and their receptors
SB Oh et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Expression of functional chemokine receptors by rat cerebellar neurons
SE Gillard et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Chemokine expression in the central nervous system of mice with a viral disease resembling multiple sclerosis: Roles of CD4(+) and CD8(+) T cells and viral persistence
RM Ransohoff et al.
JOURNAL OF VIROLOGY (2002)
Hypoxic-ischemic injury induces macrophage inflammatory protein-1 alpha expression in immature rat brain
RM Cowell et al.
STROKE (2002)
Cellular expression of functional chemokine receptor CCR5 and CXCR4 in human embryonic neurons
A Boutet et al.
NEUROSCIENCE LETTERS (2001)
Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage
P Werner et al.
ANNALS OF NEUROLOGY (2001)
Glatiramer acetate inhibition of tumor necrosis factor-α-induced RANTES expression and release from U-251 MG human astrocytic cells
QDQ Li et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCP4 in the human brain: Potential mechanisms for HIV dementia
P van der Meer et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2000)
Astrocytes express functional chemokine receptors
ME Dorf et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-β-1b
C Iarlori et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
Chemokine and chemokine-receptor expression in human glial elements -: Induction by the HIV protein, Tat, and chemokine autoregulation
CM McManus et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
beta-Chemokines and human immunodeficiency virus type-1 proteins evoke intracellular calcium increases in human microglia
CC Hegg et al.
NEUROSCIENCE (2000)
Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons
CM Coughlan et al.
NEUROSCIENCE (2000)
Share Paper
